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Abstract
Background: The large number (30) of permanent human embryonic stem cell (hESC) lines and additional 29 which did not
continue growing, in our laboratory at Karolinska Institutet have given us a possibility to analyse the relationship between
embryo morphology and the success of derivation of hESC lines. The derivation method has been improved during the
period 2002–2009, towards fewer xeno-components. Embryo quality is important as regards the likelihood of pregnancy,
but there is little information regarding likelihood of stem cell derivation.
Methods: We evaluated the relationship of pronuclear zygote stage, the score based on embryo morphology and
developmental rate at cleavage state, and the morphology of the blastocyst at the time of donation to stem cell research, to
see how they correlated to successful establishment of new hESC lines.
Results: Derivation of hESC lines succeeded from poor quality and good quality embryos in the same extent. In several
blastocysts, no real inner cell mass (ICM) was seen, but permanent well growing hESC lines could be established. One
tripronuclear (3PN) zygote, which developed to blastocyst stage, gave origin to a karyotypically normal hESC line.
Conclusion: Even very poor quality embryos with few cells in the ICM can give origin to hESC lines.
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Introduction
Early embryos at different stages of development have been
used for derivation of new hESC lines. The most common
isolation of ICM has been from 5-8-day-old blastocysts, but 9-day-
old blastocysts have also been used [1,2,3]. HESC lines have also
been derived from plating the whole blastocyst without isolation of
the ICM [4,5,6]. Earlier stage embryos have also resulted in hESC
lines [7]. Single blastomeres cultured together in groups either in
co-culture with hESC or without co-culture have generated hESC
lines [8,9,10]. One hESC line has been derived from the only
blastomere which survived thawing after cryopreservation of a 4-
cell stage embryo [11]. Efficiency of the derivation has been poor
from arrested embryos [12]. In 2008, Lerou et al. [13,14]
compared derivation of hESC from one-cell arrested embryos to
the blastocyst stage, and came to the conclusion that poor quality
embryos can generate hESC lines (1/171), but that derivation
efficiency significantly correlates with embryo status and that the
embryos that have reached the blastocyst stage to a much greater
extent generate hESC lines (8/94).
Liu et al. reported a derivation efficiency of 2.4% (4/166) when
calculated from day-three embryos. When derivation efficiency
was calculated from day-five blastocysts, it was significantly higher
(12.5%) [15].
In 2006, Stephenson et al. [16,17] first proposed that all
research groups deriving hESC lines should have a common
consensus standard for reporting established hESC lines. The
derivation methods and embryo quality and therefore hESC lines
can then be more easily compared.
Only poor-quality embryos on days two or three, with a small
likelihood of surviving freezing and thawing and generating a
pregnancy, have been donated to stem cell research in our
hospital. Good-quality embryos frozen for the maximum five-year
period which is allowed by the Swedish law have also been
donated by couples no longer interested in using them for fertility
treatments.
In this analysis, we found that we could derive hESC lines from
very poor-quality embryos as frequently as from good quality
embryos. A 3PN zygote also gave rise to a karyotypically normal
hESC line.
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We obtained approval from the Ethics Committee of Karolinska
Institutet for derivation, characterisation, and early differentiation
of hESC lines from donated supernumerary embryos. Blastocysts
were obtained as donations from infertile couples undergoing in
vitro fertilisation treatment at our Fertility Unit. Both partners
signed an informed consent form after receiving verbal and written
information. Only embryos that could not be used in infertility
treatment were used in stem cell line derivation. No payment was
made to the donors. Good quality embryos have only been
donated to stem cell derivation if they have been frozen for the
maximum of five years allowed by the Swedish law. Most of the
donated fresh embryos with a high score at the time of ICM
isolation were slow in development and were therefore not
regarded as suitable for IVF treatment. These couples always had
good-quality embryos which were transferred as their infertility
treatment.
A total of 234 embryos were donated and included in this study
between 2002 and 2009. From these embryos we managed to
derive 30 permanent fully characterised hESC lines, and 29 early
lines which did not continue to grow. The first four derivations
were carried out using foetal calf serum (FCS) in the derivation
medium [2]. The following 26 hESC lines have been derived and
cultured in serum replacement (SR), (Invitrogen, Gothenburg,
Sweden) containing media [18]. All the 30 fully characterised lines
[19] were included in the EU hESC Registry [20]. An additional
20 ICM derivation attempts were made in a xeno-free medium,
which contained X-VIVO 10 (Cambrex Bio Science Walkersville,
Inc. Walkersville, MD) as a supplement. Two early hESC lines
were obtained, but none of them continued to grow beyond
passage two.
Embryo cultures
Two different embryo culture media were used. After
aspiration, the oocytes were collected in ISM1 (Medicult, Jyllinge,
Denmark) or G1 (Vitrolife, Gothenburg, Sweden) and incubated
for 4–6 hours before insemination by IVF or ICSI. Oocyte and
embryo culture was performed in 20 ml drops of culture medium
under paraffin oil (Ovoil, Vitrolife) in an atmosphere of 6% CO2
in air at 37uC. Pronuclear formation was evaluated 16–18 hours
post-insemination (hpi), and only zygotes displaying two pronuclei
were selected for embryo transfer. The embryos were cultured
from the day of fertilisation up to day three in ISM1 or G1 and
from day three to blastocyst stage in ISM2 (Medicult) or G2
(Vitrolife). Evaluation of the embryo quality was performed at 200
times magnification using an inverted microscope equipped with
differential interference contrast optics, at 42–44 hpi and at 66–68
hpi. A modified scoring system first described by Mohr et al. [21]
was used to score and select embryos for transfer and
cryopreservation. A maximal score of 3.5 was given to the embryo
if no factor reducing embryo quality was observed. The score was
reduced in increments of 0.5 for every reducing factor observed.
The reducing factors are; non-ideal numbers of blastomeres (four
cells on day two and eight cells on day three were considered
ideal), or the presence of more than 10% fragmentation, non-
spherical blastomeres, unequal size of blastomeres, uneveness of
the cell membrane, cytoplasmic abnormalities or if the embryo did
not fill the zona pellucida.
Embryos with multi-nuclear blastomeres were not used for IVF
treatment but they could be donated for stem cell derivation.
Embryos scoring 3.0–3.5 were regarded as of top quality, those with
a score of 2.5 were considered good quality, and 4–8 cell embryos with
a score of at least 2.0 were considered suitable for cryopreservation.
Selection of blastocysts for transfer or cryopreservation was
performed at the IVF unit using the system described by Gardner
et al. [22]. The blastocoel was graded from one to six as follows: (1)
early blastocyst with a blastocoel of less than 50% of embryo
volume; (2) early blastocyst with a blastocoel of 50–80%; (3) fully
developed blastocoel of at least 80% of embryo volume; (4)
expanded blastocyst; (5) hatching blastocyst; (6) fully hatched
blastocyst. The inner cell mass was graded as follows: (A) many
cells and tightly packed; (B) average number of cells; (C) few cells
and loosely packed. The trophectoderm was graded; (A) for many
cells, equal in size and (B) for uneven cells and (C) for few cells.
Expanded blastocysts with a good inner cell mass and trophec-
toderm, i.e. at least 4AB were considered to be of high quality.
Blastocysts scoring at least 3AA were considered to be of good
quality. For an example of embryos of different scores, see Fig. 1.
Photographs of 25 of the donated embryos resulting in new hESC
lines are shown in Supporting Fig. S1. More pictures of embryos of
different scores not resulting in new hESC lines can be available
upon request.
Surplus embryos donated for stem cell research were transferred
at the blastocyst stage from the IVF unit at Karolinska University
Hospital Huddinge, Sweden, to the stem cell laboratory in the
same hospital for hESC derivation.
Isolation of the ICM
Isolation of the ICM using immunosurgery was carried out for
the first 20 hESC derivations [2] using 126 blastocysts. The zona
pellucida was first removed by using 0.5% Pronase (Sigma-Aldrich
Co., St Louis, USA) and the trophectoderm was removed by
immunosurgery as described earlier [23], using rabbit antihuman
whole serum (Sigma) and guinea-pig complement serum (Sigma).
For the following 108 blastocyst the ICMs were isolated using a
specially made flexible metal needle with a diameter of 0.125 mm,
made for us at the Helsinki School of Micromechanics (Espoo,
Finland) and now commercially available from Hunter Scientific
(Essex, UK). One needle was used to hold the blastocyst while
cutting the ICM out with a second needle, as described earlier [3].
The ICM was allowed to grow on human skin feeder cells for 12–
15 days before the first transfer to a new feeder plate. For an
example of a successful establishment of a new hESC line see
Fig. 2.
Human foreskin fibroblasts (CRL-2429; ATCC, Manassas, VA)
[2] were used as feeder cells. They were mitotically inactivated by
irradiation (40 Gy), and 100,000 cells were plated onto 2.84 cm
2
dishes (Falcon) overnight to form a confluent monolayer.
The medium for culture of the feeder cells consisted of Iscove’s
medium supplemented with 10% FCS and 0.5% penicillin-
streptomycin (all from Gibco Invitrogen Corporation). We also
tested the use of human serum for the feeder cells, and they
attached and grew similarly.
HESC culture medium
The medium used for derivation and culture of the first four
established hESC lines consisted of Knockout Dulbecco’s modified
Eagle’s medium (GibcoBRL, Life Technologies), supplemented
with 2 nmol/l L-glutamine, 20% FCS (R&D, Sweden),
0.1 mmol/l b-mercaptoethanol (Gibco), 1% non-essential amino
acids (Gibco), and recombinant human LIF, 1 ml/ml (Chemicon,
UK). Since 2003 all derivations have been carried out in
Knockout Dulbecco’s modified Eagle’s medium supplemented
with 20% Knockout SR, 2 mM Glutamax, 0.5% penicillin-
streptomycin, 1% non-essential amino acids (all from Gibco
Invitrogen Corporation), 0.5 mM 2-mercaptoethanol (Sigma) and
8 ng/ml bFGF (R&H Systems, Oxon, U.K.) [18].
Derivation of hESC Lines
PLoS ONE | www.plosone.org 2 December 2010 | Volume 5 | Issue 12 | e15329Figure 2. The successful derivation of the hESC line HS429, derived from a 3PN embryo. (A) The blastocyst with the score 4CB before
inner cell mass isolation. (B) The mechanically isolated inner cell mass on human fibroblast feeder layer. (C) One day after isolation the inner cell mass
has attached. (D) Outgrowth four days after isolation. (E) Lower magnification of the outgrowth 16 days after inner cell mass isolation, now with the
typical stem cell colony morphology. From this outgrowth a small piece had been mechanically passaged four days earlier. (F) A colony of the hESC
line HS429 at passage two. (Original magnification A–D 40x and E–F 400x). Normal karyotype 46,XX of the line HS429 at passage eight.
doi:10.1371/journal.pone.0015329.g002
Figure 1. Photographic examples representing the different scores of blastocysts donated for stem cell derivation. HS475. Fully
hatched blastocyst with clear tightly packed ICM. This embryo generated a new hESC line, HS475. Exp462. Hatching blastocyst with average number
of cells in ICM, even trophectoderm layer. Exp472. Hatching blastocyst. Trophectoderm layer is uneven and the cells in the ICM are few in number
and loosely packed. Exp404. Fully expanded blastocyst with clear tightly packed ICM and even trophectoderm layer. Exp439. Fully expanded
blastocyst, with thin zona pellucida. Small ICM and trophectoderm cells of different size. Exp412. Fully developed blastocoel. Zona pellucida is still
thick, meaning that the blastocyst is not fully expanded. Exp367. Early blastocyst. HS361. Early blastocyst with blastocoels filling less than 50% of
embryo volume. This embryo generated the hESC line HS361. Exp457. This embryo is still compacted and has not reached blastocyst stage. All
pictures were taken with a 40x objective, phase contrast or DIC, scale bar 50 mm. (Exp= experiment number. HS is used as a prefix for established
hESC lines at Karolinska Institutet).
doi:10.1371/journal.pone.0015329.g001
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supplemented by X-Vivo 10.
Propagation of the lines
The hESC lines were propagated as described earlier [18,24].
Splitting of the hESC colonies was performed mechanically at 6-8-
day intervals. Colonies were cut into smaller pieces (approximately
6–8) and then transferred onto fresh feeder cells. For passaging,
only non-differentiated cells were chosen, as judged morpholog-
ically.
Characterisation of new hESC lines
All new hESC lines were cryo-preserved as soon as sufficiently
large cell numbers were attained, at passage level two to ten. The
lines were stored in the master bank, and characterised
[2,3,18,19]. They have been used in a large number of research
projects by many laboratories.
For characterisation, expression of pluripotency markers such as
Oct-4, Nanog, SSEA-3, SSEA-4, TRA-1-60, TRA-1-81 and
SSEA-1 have been analysed using immune cyto-chemistry and
RT-PCR [2,3,18,19], see supporting Fig. S2. Microarray
expression analyses by Affymetrix two-cycle GeneChip (Affyme-
trix, Santa Clara, CA) have been carried out [25,26], and single
nucleotide (SNP) analyses have been run from two of the lines
[27,28].
For the testing of pluripotency, the hESC were differentiated
into embryoid bodies by culturing colonies of hESC as spheres in
low adhesion culture dishes in SR-containing medium, without the
addition of bFGF, for three weeks. They expressed components of
all three germ layers, bone morphogenetic protein-4 (BMP-4) for
mesoderm, nestin and sex determining region Y-box (SOX-1) for
ectoderm and alpha-fetoprotein (AFP) for endoderm.
Pluripotency was also tested in vivo by the formation of teratoma
in SCID beige mice as described earlier [18]. In brief 10
3 to 10
4
hESC were washed twice in D-PBS and put in an 1.5 mL
collection tube together with 80 mL culture medium and
subsequently implanted beneath the testicular capsule of a young
(7-week old) severely combined immunodeficient/beige male
mouse (C.B.-17/GbmsTac-scid-bgDF N7, M&B, Ry, Denmark).
Teratoma growth was determined by palpation every week and
mice were killed (cervical dislocation) eight weeks after implanta-
tion. Three to five animals were injected using each hESC line.
The teratomas were fixed, and sections were stained with
hematoxylin and eosin to analyse the presence of tissue
components of all three germ layers, see supporting Fig. S2.
Karyotype analyses were performed by G-banding. Samples of
hESCs were treated with colcemid KaryoMAX (0.1 mg/ml;Gibco)
for 5 h, trypsinised and treated for 10 min with a hypertonic
solution (0.0375 M KCl) and fixed in a 3:1 methanol and acetic
acid solution. Metaphase spreads were G-banded by brief
exposure to trypsin and stained with 4:1 Gurr’s/Leishmann’s
stain (Sigma-Aldrich). A minimum of 10 metaphases were
analysed [19].
Statistical analysis
Logistic regression analysis was performed to assess the
association between number of cells on day two and three,
morphological score day two and three, ICM score, trophecto-
derm score and expansion status with the success of establishing a
new hESC line. As prior knowledge was sparse regarding the
chosen predictors and their relationship to the success of
establishing a new hESC line, a backward selection procedure
was performed. P-values less than 0.1 were used as the exclusion
criterion.
Generalised additive models (GAM) was used to evaluate the
functional form of the relationship between each predictor and the
probability of successfully establishing a new hESC line. All
variables displayed a nonlinear relationship to the outcome and
were therefore categorised prior to the logistic regression analysis.
Cells on days two and three were classified as (,4 cells, =4 cells,
.4 cells) and (,8 cells, =8 cells, .8 cells) respectively.
Morphological score day two and three were both classified as,
,2, 2–2.5, .2.5. ICM score, trophectoderm score and expansion
status were classified as (0–1, 2, 3), (0–1, 2, 3) and (1–3, 4, .4),
respectively.
The statistical analysis was performed in SAS version 9.3 (SAS
Institute inc., Cary, NC, USA). Descriptive statistics was done in
SPSS 18.0 (SPSS Inc., Chicago, IL).
Results
Established hESC lines
We have derived 59 hESC lines since 2002, using 234 early
embryos. Thirty of these hESC lines continued to grow and are
fully characterised and banked (Table 1). Among these 30
permanent lines we have two lines from two sibling embryos,
and three lines from another set of sibling embryos.
The quality of the embryos, the number of outgrowths and
establishment of new lines are shown in Figure 3a–d.
Morphology and developmental rates of the embryos by
days two and three after fertilization
The early embryos resulting in pluripotent hESC lines had
between one and seven cells when counted on day two (see Table 1)
and the score varied between 1.0 and the maximum of 3.5 on days
two and three. On day three the numbers of cells in the early
embryos varied between two cells and ten cells for the embryos
resulting in hESC lines.
Day of ICM isolation
Fourteen blastocysts were used for derivation on day five after
fertilisation. Eleven of them (78.6%) resulted in outgrowths. We
obtained two new hESC lines from the 14 day-five blastocysts
(14%). 163 blastocysts were used for derivation on day six after
fertilisation, and 137 of these (84%) resulted in outgrowths.
Twenty-two of our 30 hESC lines were obtained from day-six
blastocysts. In addition, we obtained two early lines that were lost
at passages nine and 13. Fifty-six derivations were carried out on
seven-day-old blastocysts and 48 of the derivations (85.7%)
resulted in outgrowths. Five new hESC lines were established
from the 56 day-seven derivations. For summary of these data see
Figure 3a. (For an example of a successful establishment of a new
hESC line see Fig. 2, for pictures of the embryos resulting in new
hESC lines see supporting Fig. S1).
Expansion status
Only six early embryos were used for stem cell derivation before
reaching the blastocyst stage. They had been arrested at the
morula stage. One of the arrested embryos was a preimplantation
genetic diagnosis (PGD), Huntington’s disease. It was the only
non-blastocyst embryo that attached to the feeder layer after
removal of the zona pellucida. It did not start to proliferate.
One early blastocyst with the expansion status one (early
blastocyst with a blastocoel of less than 50% of embryo volume)
was used for isolation of the ICM. This resulted in an outgrowth
and was passaged twice. No permanent hESC line could be
established, See Figure 3b.
Derivation of hESC Lines
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PLoS ONE | www.plosone.org 5 December 2010 | Volume 5 | Issue 12 | e15329Eleven embryos with the expansion status two (early blastocyst
with blastocoel filling 50–80% of the volume of the total blastocyst)
were used for ICM isolation. 36.4% (four out of 11) resulted in
outgrowths and were further passaged, but only one (9.1%)
resulted in a permanent hESC line, HS207 (Figure 3b).
Thirty-eight of all blastocysts had expansion status three: fully
developed blastocoel filling at least 80% of embryo volume. Of
these 38 blastocysts, 16 (42.1%), resulted in an outgrowth, eight
were further passaged, and seven (22.3%) of all the embryos with
expansion status three gave rise to permanent hESC lines
(Figure 3b).
Of all 234 early embryos included in this study, 117 had the
expansion status four (fully expanded blastocysts). Fifty-four of the
blastocysts resulted in outgrowths (46.2%) and 32 were further
passaged (27.4%). Three early lines stopped growing at passage
two, one at passage nine, and one early line at passage 15. Fifteen
(12.8% of all blastocysts with expansion status four) resulted in
stable, fully characterised hESC lines (Figure 3b).
Thirty-eight derivations were carried out using blastocysts with
the expansion status five, meaning that they had started to hatch.
Twenty-two of these resulted in outgrowths and 13 could be
further passaged two or three times (34.2%). Five permanent
hESC lines were established (13.2%) out of all the blastocysts with
expansion score five (Figure 3b).
Twenty-three blastocysts with expansion status six, meaning
fully hatched, were used for ICM isolation. Thirteen (56.5%)
resulted in outgrowth. Four were passaged further (17.4%). One
promising outgrowth stopped growing at passage four. Two
permanent hESC lines were established, 8.7% of all hatched
blastocysts (Figure 3b).
ICM score
Of all derivations performed, 226 had a complete score for the
ICM. Out of these 226 blastocysts, 40 had the score A (17.7%),
122 had the score B (54.0%) and 64 blastocysts had the score C
(28.3%). Of all blastocysts with the score A for the ICM, 20 (50%)
resulted in an outgrowth and 13 (31%) were passaged further.
Seven of these resulted in hESC lines. One stopped growing early,
at passage four. The remaining six (15%) have been fully
characterised as pluripotent hESC lines (Figure 3c).
Fifty-nine (48.4%) of the 122 blastocyst with ICM score B
resulted in outgrowths. Thirty-five (28.7%) of these were passaged
Figure 3. Summary of blastocyst scores and efficiency in derivation. Percentage of successful establishment of permanent hESC lines, for
each criteria, is includes above the staple for established hESC lines. (A) Day of inner cell mass (ICM) isolation, number of isolations performed on
embryos at different days after fertilisation, number of outgrowths from these embryos and the number of successful derivations of hESC lines.
(B) Expansion Score. Number of isolations performed on embryos with different expansion scores, number of outgrowths and successful derivations.
(C) ICM Score. Number of isolations performed on embryos with different ICM scores, number of outgrowths and established hESC lines from these
embryos. (D) Trophectoderm Score. Number of isolations performed on embryos with different expansion scores, number of outgrowths and
established hESC lines.
doi:10.1371/journal.pone.0015329.g003
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PLoS ONE | www.plosone.org 6 December 2010 | Volume 5 | Issue 12 | e15329at least once. Three early lines stopped growing at passages five,
nine and 15. Eighteen permanent hESC (14.8%) lines have been
established from blastocysts with the score B for the ICM
(Figure 3c).
Sixty-four (27.4%) of all blastocyst had the score C for the ICM.
Thirty-two of these (50%) resulted in an outgrowth and were also
passaged at least once. Of the 64 blastocysts where the ICM
consisted of very few cells, six permanent hESC (9.4%) were
derived and characterised (Figure 3c).
Trophectoderm score
Twenty-five (10.7%) of all isolated blastocysts had the sore A for
the trophectoderm layer, 173 (73.9%) had the score B and 28
(11.7%) had the score C. Of the early embryos with trophecto-
derm score A, twelve (48%) resulted in an outgrowth and seven of
these were passaged further and two new hESC line was
established (8%) (Figure 3d).
Of the 173 blastocyst with trophectoderm score B, 85 (49.1%)
resulted in an outgrowth and 46 (26.6%) were passaged, three
early lines died out at passage four, five and nine, and in total 24
permanent hESC lines were established from blastocyst with score
B for the trophectoderm (13.9%) (Figure 3d).
Twenty-eight of all early embryos had the throphectoderm score
C at the blastocyst stage, meaning very few cells of different sizes.
Fourteen (50%) resulted in outgrowths, five were passaged and four
(14.3%) resulted in new permanent hESC lines (Figure 3d).
Three pronuclear zygotes
Two 3PN zygotes were donated to stem cell derivation after
reaching the blastocyst stage. Both attached to the feeder layer and
one started to grow. This 3PN embryo two days after fertilisation
had four cells and a score of 3.0, and on day three had eight cells
and a score of 3.0. On day five the embryo was still compacted,
but it had reached the blastocyst stage at day six. Eight days after
fertilisation the blastocyst had started to hatch and mechanical
isolation was performed to isolate the ICM. The derivation
resulted in the cell line HS429, which is a karyotypically normal
well-growing hESC line.
Statistical analysis
Complete information on the number of cells and morpholog-
ical score on days two and three, ICM score, trophectoderm score
and expansion status was available for 206 embryos. The only
variable that showed a significant predictive value for the
probability of successfully establishing a new hESC line was
having less than four cells on day two, P=0.018 (Table 2). No
other variables included in the model showed any significance, see
supporting Table S1.
Discussion
We managed to obtain 30 permanent and 29 early hESC lines
from 234 embryos which could not be used for infertility treatment
because of poor quality. Often the reason for excluding them from
transfer or cryopreservation was developmental delay. That is the
reason why we initially received many relatively good-quality
blastocysts for stem cell derivation. The policy in our IVF unit has
now been changed. The embryos which are not transferred or
cryopreserved at the cleavage stage are further cultured to
blastocysts and vitrified for possible infertility treatment in the
future.
The difficulties with prediction of developmental competence
were discussed earlier [29]. However, the term ‘surplus embryos’
based on the morphology on day three was questioned here, since
many of the late and also severely fragmented day-three embryos
could still develop further to the blastocyst stage. In our data we
can see that also embryos with a poor morphology on day five can
‘recover’ to a quite good morphology on day six.
Several of the hESC lines derived from embryos regarded as being
of ‘good quality’ on the day of ICM isolation were regarded as ‘poor
quality’ on day five. Both hESC lines, HS181 and HS364, when
observed by the IVF embryologists five days after fertilisation were
still compacted morulae. Therefore they were transferred to the stem
cell laboratory where they were left in culture for one more day. The
next day (day six), both embryos had developed into fully expanded
blastocysts, with the score 4BB. Two more hESC lines, HS293 and
HS400, were donated to stem cell derivation on day five with a score
of one. These were kept in culture one more day, and when ICM
isolation was performed on day six, HS293 had the score 4BB and
HS400 had the score 4AB. As a result of these findings the policy at
our fertility unit has changed. Embryos are kept for one more day in
the IVF laboratory and cryo-preserved for infertility treatment in the
future, if they develop to the blastocyst stage with the minimum score
of 2BB. Blastocysts with a lower score than 2BB, including all
embryos with a score of C for the ICM, can still be donated to stem
cell research. There are several slightly different scoring systems,
which are all based on the same criteria. We do not believe that using
different numbers in scoring would have influenced our results.
Statistical comparison of embryo quality was difficult because of
the high degree of variability. We have received 12 early embryos
regarded as top quality by the IVF unit with the score 4AA-6AA.
Only one hESC line has been successfully derived from them,
HS475. The top quality embryos did not appear to result in new
hESC lines more often than the others. Five of our hESC lines
were derived from embryos with the score C for the ICM,
meaning that the ICM contains only a few cells which are hard to
visualise. Apparently only a few pluripotent cells, perhaps only
one, are needed for the establishment of a stem cell line.
Table 2. Differences of number of cells day two.
Number of cells day 2 Number of cells day 2 Pr |t| Odds Ratio Lower Odds Ratio Upper Odds Ratio
,4 cells 4 cells 0.0181 0.274 0.094 0.800
,4 cells .4 cells 0.2540 0.468 0.127 1.731
4 cells .4 cells 0.3369 1.708 0.571 5.111
Least squares means. Having less than four cells on day two showed a significant predictive value for the probability of successfully establishing a new hESC line.
doi:10.1371/journal.pone.0015329.t002
Derivation of hESC Lines
PLoS ONE | www.plosone.org 7 December 2010 | Volume 5 | Issue 12 | e15329Only five embryos arrested at the cleavage stage were included
in this study. None of them resulted in any outgrowth after plating
on feeder cells.
We derived hESC lines from embryos regarded as having too
poor quality by IVF standards for cryo-preservation, the lowest
score being 2CB (cell line HS207). One blastocyst had 3PN when
observed one day after fertilisation. For this reason this embryo
was regarded as not being suitable for IVF treatment and was
donated for stem cell derivation. Six days after fertilisation the
blastocyst was fully expanded. Mechanical isolation of the ICM
was performed, and the ICM was plated onto feeders. The result
was a well growing hESC line, HS429. When analysed at passage
eight it had the normal female karyotype 46XX. The line has
grown well and remained karyotypically normal at high passages.
We can only speculate why this 3PN embryo resulted in a hESC
line with a normal karyotype. One reason could be that when the
early zygote was observed, one day after fertilisation, one polar
body had still not been extruded, but that this process happened
later on. There is also the possibility of normalisation: that the
extra sets of chromosomes had been excluded from metaphase and
then discarded by the developing embryo. It has been previously
shown that 3PN zygotes can be rescued to heteroparental
blastocysts by microsurgical correction [30,31]. Sathananthan et
al. [32] have previously described the development of human
dispermic embryos. Ten out of 103 3PN zygotes developed to the
blastocyst stage. In a case report in 2003, Kattera and Chen
described how microsurgical enucleation of a single pronucleus
from three 3PN zygotes was performed, and the embryos were
transferred to a woman for fertility treatment. The result was a
normal healthy baby [33]. No earlier derivation of hESC has been
reported from 3PN embryos.
A high proportion of human oocytes are affected by
chromosomal abnormalities, but the vast majority of such embryos
are unable to develop to blastocyst stage, fail to implant or
culminate in a miscarriage [34]. All our 30 hESC lines have been
derived from embryos at blastocyst stage. A recent study came
with the conclusion that embryo morphology screening might be a
better tool than genetic screening for at least a part of the IVF
patients [35]. It is interesting to note that large chromosomal
abnormalities such as aneuploidy in hESC lines at low passages are
not common. Smaller changes seen in hESCs seem to most often
appear due to culture adaptations and they are not inherited from
the germ cells [28].
In 2006, Zhang et al. [12] described the derivation of two hESC
lines from 15 arrested morula stage embryos, but we were not
successful in our six such attempts.
We have experience from deriving 30 permanent, and the
additional 29 early lines that have been lost either due to
differentiation, lack of proliferation or infection (one) before the
line could be cryo-stored. On this basis, we can say that both high-
quality and poor-quality embryos, and even those containing three
pronuclei, can generate pluripotent hESC lines that grow well.
Our success rate in derivation of permanent hESC lines was
12.8% (30/234) in 2001-2009. Here we tried to see if we can
foresee the likelihood for an embryo of generating a stem cell line
by calculating on the scores from day two, three and on the day of
derivation, and the number of cells in the early dividing embryo.
We compared the different data sets individually or in combina-
tion. The only data of significance was the number of cells on day
two. Embryos with fewer than four cells had a significant
advantage in derivation success compared to embryos with four
cells on day two. This correlation with the number of cells, and the
likelihood of generating a new cell line was, however, lost on day
three. The likelihood of pregnancy is highest when the embryo on
day two has exactly four blastomeres, but this parameter does not
anticipate stem cell line derivation success.
Our conclusion is that all embryos donated to research that
have reached blastocyst stage can give rise to new hESC lines, and
attempts should be made even if the blastocyst has a poor score.
Supporting Information
Figure S1 Pictures of 25 of the early embryos that have resulted
in established hESC lines with the score at the time of derivation.
(TIF)
Figure S2 Panel shows teratoma formation from cell line
HS401, A. Neural tissue ectoderm 10X, B. Intestinal endoderm
20X, C Cartilage mesoderm 10X. D. Shows expression of
pluripotency markers by immunostaining of cell line HS207.
(TIF)
Table S1 Logistic regression analysis was performed to assess the
association between number of cells on days two and three,
morphological score on days two and three, ICM score,
trophectoderm score and expansion status with the success of
establishing a new hESC line. Statistical predictive value was only
seen for the number of cells on day two after fertilisation.
(DOC)
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